These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies. Honnorat J; Cartalat-Carel S; Ricard D; Camdessanche JP; Carpentier AF; Rogemond V; Chapuis F; Aguera M; Decullier E; Duchemin AM; Graus F; Antoine JC J Neurol Neurosurg Psychiatry; 2009 Apr; 80(4):412-6. PubMed ID: 18931014 [TBL] [Abstract][Full Text] [Related]
26. Bilateral temporal glioma presenting as a paraneoplastic limbic encephalitis with pure cognitive impairment. Deramecourt V; Bombois S; Debette S; Delbeuck X; Ramirez C; Reyns N; Kerdraon O; Maurage CA; Pasquier F Neurologist; 2009 Jul; 15(4):208-11. PubMed ID: 19590380 [TBL] [Abstract][Full Text] [Related]
27. Double trouble: para-neoplastic anti-PCA-2 and CRMP-5-mediated small fibre neuropathy followed by chorea associated with small cell lung cancer and evolving radiological features. Waheed W; Boyd J; Khan F; Mount SL; Borden NM; Tandan R BMJ Case Rep; 2016 Aug; 2016():. PubMed ID: 27571910 [TBL] [Abstract][Full Text] [Related]
28. Limbic encephalitis and antibodies to Ma2: a paraneoplastic presentation of breast cancer. Sutton I; Winer J; Rowlands D; Dalmau J J Neurol Neurosurg Psychiatry; 2000 Aug; 69(2):266-8. PubMed ID: 10896708 [TBL] [Abstract][Full Text] [Related]